• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® CARDIOFORM SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® CARDIOFORM SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL Back to Search Results
Catalog Number GSX0030A
Device Problem Migration or Expulsion of Device (1395)
Patient Problem Respiratory Distress (2045)
Event Date 03/30/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).The review of the manufacturing records verified that this lot met all pre-release specifications.The imaging evaluation states that upon review of the fluoroscopic still image of the released device, it appears a portion of the left disc appears to be deployed on the right side of the septum, however this cannot be confirmed without echocardiographic images.Per the ifu a minimum occluder to defect size ratio of 1.75:1 is recommended.The defect size should be no greater than 17 mm.
 
Event Description
It was reported to gore a 30mm gore® cardioform septal occluder was selected to close an atrial septal defect with a mobile septum primum.The defect measured 17.6mm by intracardiac echocardiogram and 19mm by fluoroscopy.The device was deployed and locked and it was reported the physician felt the device was in good position.It was reported that later that day the patient experienced a coughing episode.An echocardiogram was performed and showed the device had embolized to the mitral valve.The patient was taken to surgery and the device was successfully removed and the defect closed.It was reported that during removal of the device it was observed that the anterior leaflet of the device had attached to a tendinae of the mitral valve, resulting in mitral valve stenosis and insufficiency.The patient was reported to be doing well and was discharged on (b)(6) 2017.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM SEPTAL OCCLUDER
Type of Device
OCCLUDER, TRANSCATHETER SEPTAL
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
kathy titus
9285263030
MDR Report Key6519793
MDR Text Key73624663
Report Number2017233-2017-00221
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/31/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/25/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/02/2018
Device Catalogue NumberGSX0030A
Device Lot Number15648204
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/02/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age7 YR
Patient Weight25
-
-